Medication info
Starzin 100 mg (Sitagliptin Phosphate)

Starzin 100 mg (Sitagliptin Phosphate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate›124.08mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Beige, bilaterally convex, round film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP X 3]
Approval status
Active

MFDS item code 201503223 · Approved 2015.05.27 · Insurance code 648103610

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to aid blood sugar control in patients with type 2 diabetes mellitus. It can also be administered as monotherapy, and in cases where monotherapy alone does not achieve sufficient blood sugar control without prior experience with diabetes medication, it may be used together with metformin. Additionally, this medication is combined with sulfonylureas, metformin, thiazolidinediones, or insulin when blood sugar control is not well managed with these monotherapies. Furthermore, this medication can be added for combination therapy in situations where adequate blood sugar control is not achieved with various drug combinations. It is used to improve blood sugar control tailored to these diverse circumstances.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may very rarely cause severe allergic reactions after administration; hence, if symptoms like skin rash or difficulty breathing occur, usage should be stopped immediately and a doctor should be consulted. There are reports of a serious side effect called acute pancreatitis, which is inflammation of the pancreas, so if symptoms such as abdominal pain or vomiting manifest, immediate medical attention is required. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, nor should anyone who is allergic to this drug or its ingredients. Patients with impaired kidney function may need dosage adjustments; therefore, those with kidney disease should inform their doctor. Hypoglycemic symptoms may occur when using this medication, particularly when taken together with insulin or sulfonylureas, so blood sugar levels should be checked frequently and hypoglycemic symptoms should be monitored closely. Rarely, side effects such as arthralgia or the formation of blisters on the skin have been reported; if such symptoms occur, immediate communication with healthcare personnel is necessary. Pregnant or breastfeeding women are advised against using this medication, and safety has not been established for children under 18 years of age. Elderly patients may have decreased kidney function, so it is important to have kidney function tests before taking this medication and to regularly check kidney status during use. In the case of overdose, while standard treatment is generally applied, dialysis may be performed if necessary to remove the medication, so caution should be exercised to avoid exceeding the recommended dose. Finally, this medication may interact with other diabetes treatments or certain medications; thus, all currently taken medications should be disclosed to a doctor and used according to their guidance.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory tract infection
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe joint pain with disability
  • blistering dermatitis
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air, and it is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy over time.

Appearance and packaging

Appearance

Beige, bilaterally convex, round film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.